Meningioma: Novel Diagnostic and Therapeutic Approaches

Meningioma: Novel Diagnostic and Therapeutic Approaches

<b>Background/Objectives</b>: Meningiomas are the most common intracranial tumors. Surgery and radiation therapy are the cornerstones of treatment and no standard of care therapy exists for refractory meningiomas. This manuscript aims to provide a comprehensive review of novel diagnostic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Carlen A. Yuen, Michelle Zheng, Max A. Saint-Germain, David O. Kamson
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Series:	Biomedicines
Subjects:	meningioma 177-Lutetium PRRT DOTATATE PET octreotide <i>NF2</i>
Online Access:	https://www.mdpi.com/2227-9059/13/3/659
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multifactorial analysis of radiochemical purity in high-activity 177Lu-labeled theranostics: impact of precursor source, 177Lu form, and production parameters
by: William Hunt, et al.
Published: (2025-07-01)

An Update on DOTA-Peptides PET Imaging and Potential Advancements of Radioligand Therapy in Intracranial Meningiomas
by: Viviana Benfante, et al.
Published: (2025-04-01)

Quantitative 177Lu-DOTATATE SPECT/CT is predictive of 6-month PRRT morphological response in midgut neuroendocrine tumors: a pilot study
by: Iness Megherbi, et al.
Published: (2025-05-01)

COMPETITION RESPONSE OF PSMA-I&T RADIOLABELED WITH LUTETIUM-177 TO LNCAP, PC-3 AND RWPE-1 CELLS
by: Luiza M Balieiro, et al.
Published: (2025-05-01)

“Rosary Sign” at Somatostatin Receptor PET in a Case of Recurrent Meningioma
by: Cesare Michele Iacovitti, et al.
Published: (2024-11-01)

Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy
by: Turgut Bora Cengiz, et al.
Published: (2025-01-01)

Metastatic neuroendocrine tumor with extensive bone marrow involvement at diagnosis: Evaluation of response and hematological toxicity profile of PRRT with 177Lu-DOTATATE
by: Sandip Basu, et al.
Published: (2016-01-01)

Selection and Use of Antioxidants-radioprotectors in the Composition of Therapeutic Radiopharmaceuticals (Review)
by: E. P. Pavlenko, et al.
Published: (2023-12-01)

Peptide receptor radionuclide therapy in the management of neuroendocrine tumors (Neoplasms)*: Fundamentals and salient clinical practice points for medical oncologists
by: Sandip Basu, et al.
Published: (2019-01-01)

Optimization of PSMA-I&T radiolabeling with 177Lu
by: Luiza Mascarenhas Balieiro, et al.
Published: (2025-06-01)

RM2 and DB15 analogues bearing [177Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative study
by: Panagiotis Kanellopoulos, et al.
Published: (2025-07-01)

Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of 177Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors
by: Rahul V. Parghane, et al.
Published: (2019-04-01)

Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of177Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors
by: Rahul V Parghane, et al.
Published: (2019-01-01)

Optimizing Standardization Systems and Standardizing Clinical Practice: Interpretation of Quality Standards for Medical 68Ge/68Ga Generators and 68Ga Radiopharmaceuticals and Quality Standards for Medical 177Lu and Its Radiopharmaceuticals
by: LAI Yuxin, et al.
Published: (2025-07-01)

Very good effect of rescue treatment with 177Lu-DOTATATE in the patient with advanced metastatic atypical lung carcinoid
by: Małgorzata Elżbieta Poniatowska, et al.
Published: (2025-01-01)

177Lu‐Gold Nanohybrids in Radiotherapeutic Approaches Against Cancer
by: Mathilde Ponchelle, et al.
Published: (2025-05-01)

Predicting the Response of Patients Treated with 177Lu-DOTATATE Using Single-photon Emission Computed Tomography-Computed Tomography Image-based Radiomics and Clinical Features
by: Baharak Behmanesh, et al.
Published: (2024-10-01)

The South Australian 177Lu-DOTATATE peptide receptor radionuclide therapy service: an 11-year review of toxicity, health-related quality of life, and survival
by: L.M. Altus, et al.
Published: (2025-06-01)

Bias and precision of SPECT-based 177Lu activity-concentration estimation using a ring-configured solid-state versus a dual-headed anger system
by: Anna Stenvall, et al.
Published: (2024-11-01)

Improvement of End-of-Synthesis Radiochemical Purity of <sup>177</sup>Lu-DOTA-PSMA-Ligands with Alternative Synthesis Approaches: Conversion Upswing and Side-Products Minimization
by: Anton Larenkov, et al.
Published: (2024-11-01)

177Lu-DOTATATE peptide receptor radionuclide therapy in metastatic or advanced and inoperable primary neuroendocrine tumors of rare sites
by: Pradeep Thapa, et al.
Published: (2017-07-01)

Staging Gallium-68 DOTATATE PET/CT Imaging in Neuroendocrine Tumors: Relationship between Measured SUVmax of the Primary Tumor and the Pathological Grade and Ki-67 Proliferation Index
by: Emin Büyüktalancı, et al.
Published: (2025-02-01)

Cystic Angiomatous Meningioma: A Diagnostic Dilemma
by: Sumit Bansal, et al.
Published: (2016-06-01)

Predictive factors for persistent thrombocytopenia after peptide receptor radioligand therapy in enteropancreatic neuroendocrine tumors
by: Romain Ferrara, et al.
Published: (2025-05-01)

Malignant Meningiomas: From Diagnostics to Treatment
by: Hojka Rowbottom, et al.
Published: (2025-02-01)

Features and Practical Aspects of Radiochemical Purity Determination of Receptor-Specific Lu-177 Radiopharmaceuticals as Exemplified by [<sup>177</sup>Lu]Lu–PSMA-617
by: A. A. Larenkov, et al.
Published: (2022-12-01)

Novel <sup>177</sup>Lu-Labeled [Thz<sup>14</sup>]Bombesin(6–14) Derivatives with Low Pancreas Accumulation for Targeting Gastrin-Releasing Peptide Receptor-Expressing Cancer
by: Lei Wang, et al.
Published: (2025-03-01)

Synthesis and Evaluation of <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled [diF-Pro<sup>14</sup>]Bombesin(6−14) Analogs for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing Cancer
by: Lei Wang, et al.
Published: (2025-02-01)

Intramyocardial Hemangioma Mimicking Paraganglioma in Cardiac MRI and DOTANOC PET
by: Venkata Subbaih Arunachalam, et al.
Published: (2025-07-01)

Meningiomas císticos
by: J. F. M. Araújo, et al.
Published: (1993-11-01)

Mechanistic role of miR-375 in regulating PDPK1 to promote progression of small bowel neuroendocrine tumors: a silico analysis
by: Tao Ren, et al.
Published: (2025-06-01)

Peptide receptor radionuclide therapy with 177Lu-DOTATATE for metastatic neuroendocrine tumor occurring in association with multiple endocrine neoplasia type 1 and cushing's syndrome
by: Chinna Naik, et al.
Published: (2017-04-01)

177Lu-DOTATATE and 177Lu-prostate-specific membrane antigen therapy in a patient with advanced metastatic radioiodine-refractory differentiated thyroid cancer after failure of tyrosine kinase inhibitors treatment
by: Majid Assadi, et al.
Published: (2019-10-01)

Clinical efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in thyroglobulin-elevated negative iodine scintigraphy: A “not-so-promising” result compared to GEP-NETs
by: Sandip Basu, et al.
Published: (2020-07-01)

GSTM1 null genotype underpins recurrence of NF2 meningiomas
by: Anthony C. Johnson, et al.
Published: (2024-12-01)

PSMA PET/CT scan reveals incidental meningioma in a prostate cancer patient
by: Venetia A. Florou, et al.
Published: (2025-05-01)

Peptide Receptor Radionuclide Therapy Using <sup>90</sup>Y- and <sup>177</sup>Lu-DOTATATE Modulating Atherosclerotic Plaque Inflammation: Longitudinal Monitoring by <sup>68</sup>Ga-DOTATATE Positron Emissions Tomography/Computer Tomography
by: German Rubinstein, et al.
Published: (2024-11-01)

Meningiomas múltiplos e neurofibromatose: relato de três casos
by: Mauro A. Oliveira, et al.
Published: (1993-06-01)

Multiple meningiomas within the spinal canal: case report with 23 tumors Meningiomas intrarraqueanos múltiplos: relato de caso com 23 tumores
by: José Alberto Gonçalves da Silva, et al.
Published: (2005-03-01)

Meningioma secretório: relato de dois casos Secretory meningioma: a report of two cases
by: João Norberto Stávale, et al.
Published: (1997-09-01)